Work

Good T cells for bad B cells

Year: 2012

Type: article

Abstract: In this issue of Blood , Kochenderfer and colleagues update their results of a phase 1 trial describing the infusion of autologous T cells rendered specific for CD19.[1][1] Their data build on the safety, feasibility, and efficacy regarding adoptive transfer of genetically modified T cells

Source: Blood

DOI: 10.1182/blood-2011-12-398719

Authors: Laurence J. N. Cooper, Bipulendu Jena, Catherine M. Bollard

Institutions: The University of Texas MD Anderson Cancer Center, Baylor University, Baylor College of Medicine

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute